Search

everythinglearnresearchcommunity

for

Search:↓

Core symptoms in breast cancer chemotherapy remain stable, aiding targeted interventions.

A systematic approach is crucial for managing hair loss in women.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Lepidium sativum seed extracts helped reduce inflammation and improve insulin response in obese rats on a high-fat diet.

Phyto-vesicles of β-sitosterol may effectively treat hair loss.

Cuscuta reflexa extracts helped regrow hair in rats with drug-induced hair loss.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

A man lost all his hair as a rare side effect after hepatitis C treatment.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Agomelatine might help stop hair loss caused by valproate.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Combining exosomes with microneedling may improve hair growth in androgenetic alopecia.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Microneedles help improve skin appearance and deliver skin treatments effectively, but safety concerns need more research and regulation.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.